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Background-—Healthcare resources vary geographically, but associations between hospital-based resources and acute stroke
quality and outcomes remain unclear.
Methods and Results-—Using Get With The Guidelines-Stroke and Dartmouth Atlas of Health Care data, we examined associations
between healthcare resource availability, stroke care, and outcomes. We categorized hospital referral regions with high-, medium-,
or low-resource levels based on the 2006 national per-capita availability median of 6 relevant acute stroke care resources. Using
multivariable logistic regression, we examined healthcare resource level and in-hospital quality and outcomes. Of 1 480 308
admitted ischemic stroke patients (2006–2013), 28.8% were hospitalized in low-, 44.4% in medium-, and 26.9% in high-resource
hospital referral regions. Quality-of-care/timeliness metrics, adjusted length of stay, and in-hospital mortality were similar across
all resource levels.
Conclusions-—Signiﬁcant variation exists in regional availability of healthcare resources for acute ischemic stroke treatment, yet
among Get With the Guidelines-Stroke hospitals, quality of care and in-hospital outcomes did not differ by regional resource
availability. ( J Am Heart Assoc. 2017;6:e003813. DOI: 10.1161/JAHA.116.003813.)
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A cute stroke is a leading cause of death and disability inthe United States.1 In-hospital management of stroke is
complex and costly, and availability of resources for the
treatment of stroke varies by geographic region.2–4 The
relationship between resource utilization and acute stroke
patient quality of care and outcomes has not been fully
established. Access to stroke specialists can support the
identiﬁcation of high-risk patients and selection of those
who will beneﬁt from acute interventions that are available
at specialized stroke centers.5 However, results from a
number of studies indicate that patients living in regions
with more healthcare resources or a greater degree of
healthcare spending may not experience higher quality
care or better outcomes than those living in regions with
fewer resources.6–9 Whether greater regional healthcare
resource availability is associated with better quality of
acute stroke care and improved clinical outcomes remains
unclear.
We examined the geographic variation in per-capita
healthcare resources available for the treatment of acute
stroke using publicly available data from the Dartmouth Atlas
of Health Care (DAH) and in-hospital data from the Get With
The Guidelines-Stroke (GWTG-Stroke) quality improvement
initiative. We also estimated the association between avail-
ability of resources relevant to the treatment of acute stroke
and quality of care in addition to in-hospital outcomes,
including complications and mortality.
Methods
Data Sources
We linked data from the American Heart Association’s GWTG-
Stroke to DAH to ascertain information on healthcare
resource distribution. GWTG-Stroke is an ongoing, national
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quality improvement initiative begun in 2003 to optimize care
for hospitalized stroke patients by improving adherence to
evidence-based guidelines. Trained personnel enter deidenti-
ﬁed demographic, clinical, and event information at partici-
pating sites. Details of the GWTG-Stroke program have been
previously described.10,11 The DAH is a publicly available data
set that provides numbers of physicians by specialty, hospital-
based registered nurses, and inpatient beds per 100 000
residents for individual hospital referral regions (HRRs) in the
United States.7 Healthcare resource data are available from
2003 to 2007. We linked GWTG-Stroke hospitals to referral
regions using a crosswalk ﬁle from the DAH that links HRR
number to zip code for each GWTG-Stroke hospital. There are
a total of 306 HRRs deﬁned in the 2006 DAH resource data;
the linked GWTG-Stroke hospitals represented 301 of the
HRRs. The 5 HRRs not represented in GWTG-Stroke include:
(1) Tuscaloosa, Alabama (HRR #9); (2) San Luis Obispo,
California (HRR #83); (3) Covington, Kentucky (HRR #203); (4)
Hickory, North Carolina (HRR #315); and (5) Elyria, Ohio (HRR
#331).
Study Population/Exclusions
Our starting population included 1 525 113 GWTG-Stroke
patients aged 18 years and older who were discharged from
1988 sites (January 2006–September 2013) with a ﬁnal
clinical diagnosis indicating ischemic stroke. We excluded
patients seen at hospitals with >25% missing medical history
data (n=41 632), as well as patients seen at hospitals not in
the DAH crosswalk (n=3173). After exclusions, our ﬁnal
analytic population consisted of 1 480 308 patients from
1898 clinical sites.
Exposure Deﬁnition
Healthcare resource categories were deﬁned according to
the per 100 000 population number of the following:
neurologists, radiologists, emergency room physicians,
physical medicine and rehabilitation specialists, hospital-
based registered nurses, and number of inpatient hospital
beds.
We calculated median levels of healthcare resources based
on the per-capita distribution of resources for all HRRs in the
study sample. We then classiﬁed each HRR as high (>50th
percentile in at least 5 resource categories), medium (>50th
percentile in 3 or 4 categories), or low (>50th percentile in
fewer than 3 categories) to produce groups of relatively
comparable size and promote stability in effect estimates. The
distributions of each healthcare resource are provided in
Table S1. In a sensitivity analysis, we examined the associ-
ation between clinical outcomes and each of the 6 individual
resources (Table S2).
Outcome Deﬁnition
The primary outcome of interest was performance on quality-
of-care indicators and timeliness metrics, estimated at the
patient level. Receipt of quality-of-care metrics was estimated
for eligible patients only and included venous thromboem-
bolism prophylaxis for patients not ambulating by hospital day
2, antithrombotics by hospital day 2, tissue plasminogen
activator (tPA) within 3 hours for patients arriving within
2 hours of symptom onset, anticoagulation for atrial ﬁbrilla-
tion, antithrombotics at hospital discharge, lipid-lowering
mediation at discharge, dysphagia screening, stroke educa-
tion, smoking cessation counseling, and assessment for
rehabilitation services.12,13 We also considered performance
on a global composite measure, defect-free care, which was
deﬁned as the receipt of all performance measures for which
the patient was eligible. Timeliness metrics included door-to-
brain imaging within 25 minutes, door-to-needle time within
60 minutes for tPA patients, and treatment by 4.5 hours for
tPA patients who arrived within 3.5 hours. Secondary out-
comes of interest were also estimated at the patient level and
included in-hospital complications (pneumonia, deep vein
thrombosis/venous thromboembolism, and tPA-related com-
plications), length of inpatient hospital stay, in-hospital
mortality, discharged to home, and independent ambulatory
status at discharge.
Statistical Analysis
Baseline characteristics, comorbidities, and laboratory data
are described overall and by resource availability (high,
medium, or low). Categorical variables are presented as
counts and proportions; continuous variables are presented
as medians with 25th and 75th percentiles. Quality-of-care
and timeliness metrics are compared by resource availability
using standardized differences. We evaluated the association
between healthcare resource availability and length of inpa-
tient hospital stay using multivariable linear regression
models. Length of inpatient hospital stay was log-transformed
for normality assumptions of the linear regression. The
association between resource availability and in-hospital
outcomes, including mortality and complications, was
assessed using standardized differences (unadjusted) and
multivariable logistic regression (adjusted models). All regres-
sion models used generalized estimating equations to account
for clustering of patients and were adjusted for clinical and
hospital characteristics (demographics, comorbidities, medi-
cation use, event characteristics, hospital bed size, teaching
status, region, and urban/rural location). For linear regression
analyses, linearity was assessed for the relationship between
continuous adjustment variables and outcomes and transfor-
mations applied, as needed. Single imputation was used for
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missing values, with missing values for continuous variables
imputed to the median, and missing values for categorical
variables to the most frequent category. Variables with a
missing rate of >20% were not considered for adjustment.
Since stroke severity is an important predictor of length of
hospital stay and clinical outcomes, a sensitivity analysis
further adjusted for stroke severity using the National
Institutes of Health Stroke Scale in the subset of patients
with non-missing National Institutes of Health Stroke Scale
scores (n=898 148; 60.7%). All statistical analyses were
performed using SAS software version 9.3 (SAS Institute, Inc.,
Cary, NC). We considered P<0.05 to be statistically signiﬁcant
for all analyses. The GWTG-Stroke study was approved by
Duke’s institutional review board. All participating hospitals
received either approval to enroll without individual patient
consent under the common rule or a waiver of exemption
from subsequent review by institutional review boards.
Results
Of 1898 hospitals included in the analysis, 29.1% were in low-
resource regions, 45.5% in medium-resource regions, and
25.4% in high-resource regions. Of 1 480 308 patients
enrolled in GWTG-Stroke from 2006 to 2013, 28.8% were
hospitalized at sites in low-resource regions, 44.3% in
medium-resource regions, and 26.9% in high-resource regions
(Figure). The distribution of patient and event characteristics
by regional resource level is provided in Table 1. Age and sex
distributions were similar across resource levels, but patients
hospitalized in medium-resource regions were more likely to
be white than those in low- or high-resource regions.
Comorbidity burden was similar across resource levels, with
comparable rates of prior stroke/transient ischemic attack,
diabetes mellitus, coronary artery disease, hypertension, and
heart failure across low-, medium-, and high-resource regions.
Examination and laboratory data, including body mass index,
systolic blood pressure, and cholesterol did not vary substan-
tially by resource region. Patients hospitalized in high-
resource regions were more likely to arrive by emergency
medical services, but had longer prehospital delays than those
hospitalized in lower-resource regions.
Table 2 presents the distribution of evidence-based care
metrics by resource region. Receipt of defect-free care was
slightly higher for patients hospitalized in high-resource
regions. Patients hospitalized in high-resource regions were
slightly more likely to receive venous thromboembolism
prophylaxis, antithrombotics at discharge, statins at dis-
charge, and smoking cessation counseling than those seen at
sites in lower-resource regions; however, standardized differ-
ences for these metrics were all less than 10% (the a priori
threshold indicating negative correlation between the expo-
sure group and the binary variable14). We observed small
differences in the proportion of patients meeting timeliness
metrics by resource region, with higher proportions of
patients receiving tPA within 3 hours and meeting the door-
to-needle time of 60 minutes from hospital arrival to tPA
administration. On average, patients hospitalized in low-
resource regions were less likely to be cared for in a stroke
unit (28.1%) than patients in medium- (33.7%) or high- (38.6%)
resource regions (P=0.014).
The results from a multivariable regression analysis
comparing in-hospital outcomes across resource regions are
provided in Table 3. After adjusting for demographics, clinical
comorbidities, and event characteristics, we found similar
rates of venous thromboembolism complications and tPA
complications among patients hospitalized at low-, medium-,
and high-resource sites (unadjusted hospital-level rates
provided in Table S3). Compared with low-resource regions,
adjusted in-hospital mortality (odds ratio [OR]; 95% CI) was
similar in high-resource regions (OR, 1.00; CI, 0.92, 1.09
[P=0.92]) and slightly higher in medium-resource regions (OR,
1.09; CI, 1.02, 1.16 [P=0.01]). Examination of two indicators
of positive poststroke discharge outcomes—discharge to
home and ambulating independently at discharge—did not
reveal differences among patients in low-, medium-, or high-
resource regions (Table 3). Median length of hospital stay was
similar across regions. Results from a sensitivity analysis
limited to the population of patients with complete informa-
tion on stroke severity (National Institutes of Health Stroke
Scale) were similar to those results from the overall analysis
(data not shown). In a second sensitivity analysis with HRRs
reclassiﬁed as low (1 category in >50th percentile), medium
(2 or 3 categories in >50th percentile), and high (4+
categories in >50th percentile), re-results were similar for
all comparisons except for the comparison of high- versus
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Figure. Proportion of hospital resource regions (HRRs) and Get
With The Guidelines-Stroke patients by resource category. This
ﬁgure displays the proportion of HRRs and patients enrolled in Get
With The Guidelines-Stroke Registry by hospital resource level,
based on availability per 100 000 residents of neurologists,
radiologists, emergency room physicians, physical medicine and
rehabilitation specialists, hospital-based registered nurses, and
inpatient hospital beds.
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low-resource availability and in-hospital mortality, which was
not signiﬁcant in the original analysis but became signiﬁcant
in the reclassiﬁed analysis (Table S4).
In a sensitivity analysis examining outcomes by each of the
6 individual healthcare resources, we found that greater
availability of neurologists and physical medicine and rehabil-
itation specialists (per 100 000 residents) and fewer inpatient
beds (per 100 000 residents) were associated with higher
adjusted rates of defect-free care (Table S2). Greater
availability of neurologists, physical medicine and rehabilita-
tion specialists, and inpatient hospital beds were associated
with greater length of hospital stay. No associations were
observed for individual resource availability and in-hospital
mortality, ambulatory status at discharge, tPA-related com-
plications, or venous thromboembolism.
Discussion
In this study, we examined the availability of 6 healthcare
resources relevant to acute ischemic stroke and length of
stay, rates of complications, and in-hospital mortality. We had
several major ﬁndings. First, the majority of patients with
acute ischemic stroke enrolled in GWTG-Stroke were hospi-
talized in medium-resource regions, followed by low-resource
and-high resource regions. Second, comorbidity burden was
similar across patients admitted for acute ischemic stroke to
hospitals in high-, medium-, and low-resource HRRs. Third,
hospitals in high- and medium-resource HRRs were more
likely to deliver defect-free care than those in low-resource
HRRs, but this difference was small. Finally, among hospi-
tals participating in GWTG-Stroke, adjusted estimates of
Table 1. Baseline Patient Characteristics by Regional Resource Level
Variable*
HRR Resource Level† Standardized Differences
Low (n=425 516) Medium (n=656 348) High (n=398 444) Medium vs Low High vs Low
Demographics
Median age, y (25th, 75th percentiles) 72.0 (60.0, 82.0) 73.0 (61.0, 83.0) 73.0 (60.0, 82.0) 4.4 2.3
Female sex, No. 51.1 51.6 52.4 1.0 2.7
White race, No. 69.4 73.3 69.4 9.0 0.1
Medical history, No.
CAD/prior MI 25.8 25.8 27.1 0.1 2.9
Diabetes mellitus 32.5 31.5 32.4 2.2 0.2
Prior stroke/TIA 30.8 30.3 31.1 1.1 0.6
Smoking 18.6 18.3 19.3 1.0 1.6
AF 17.3 18.8 18.4 4.0 2.9
HF 7.0 7.4 8.1 1.5 4.0
Hypertension 75.1 75.2 76.4 0.2 3.1
Laboratory and examination data
BMI, kg/m2, median (25th, 75th percentiles) 26.8 (23.4, 31.1) 26.9 (23.4, 31.2) 27.1 (23.5, 31.4) 0.6 3.2
SBP, mm Hg, median (25th, 75th percentiles) 154 (135, 176) 154 (136, 176) 154 (136, 176) 0.4 1.6
Total cholesterol, mg/dL, median (IQR) 167 (139–200) 167 (138–199) 167 (139–200) 1.2 0.1
LDL-C, mg/dL, median (25th, 75th percentiles) 98 (75, 126) 98 (74, 125) 98 (74, 126) 1.7 1.3
Event characteristics
EMS arrival 48.3 47.6 50.2 1.4 3.8
Median prehospital delay, min 699 (141, 2118) 694 (145, 2110) 717 (162, 2149) 0.0 0.0
Ambulating by day 2 44.2 44.2 41.7 0.1 5.1
NIHSS score, median 4.0 (2.0, 11.0) 4.0 (2.0, 10.0) 4.0 (2.0, 10.0) 2.8 3.6
AF indicates atrial ﬁbrillation; AMI, acute myocardial infarction; BMI, body mass index; CAD, coronary artery disease; EMS, emergency medical services; HF, heart failure; HRR, hospital
referral region; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood
pressure; TIA, transient ischemic attack.
*Chi-square tests used for categorical variables and Kruskal–Wallis tests for continuous variables. All P values for comparison were <0.0001. Values are percentages unless otherwise
indicated.
†Based on availability per 100 000 residents of neurologists, radiologists, emergency room physicians, physical medicine and rehabilitation specialists, hospital-based registered nurses,
and inpatient hospital beds.
DOI: 10.1161/JAHA.116.003813 Journal of the American Heart Association 4
Healthcare Resources and Stroke Outcomes O’Brien et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
in-hospital outcomes did not differ by availability of the 6
selected resource metrics.
Facilitating access to specialized care has received increas-
ing focus as a mechanism for reducing stroke morbidity and
mortality, as evidenced by numerous recent telemedicine and
related initiatives aimed at increasing access to stroke
specialists in under-resourced and underserved popula-
tions.15,16 These efforts are founded on a growing body of
evidence suggesting that involvement of nursing and physician
specialists in acute stroke care may have a direct impact on
health outcomes.17 In a population of patients treated at 42
academic medical centers in the University Health Systems
Consortium, in-hospital mortality rates were substantially lower
in academic centers with a vascular neurologist, as well as
thosewho limited tPA administration to neurologists, compared
with other academic centers.18 In a comparison of in-hospital
outcomes in patients in the Veterans Affairs Stroke Study
treated by either a neurologist or a non-neurologist, Goldstein
and colleagues19 reported that patients treated by a neurologist
were 37% less likely to be dead or dependent at discharge,
Table 2. Healthcare Resource Availability and Acute Stroke Care
HRR Resource Level, %* Standardized Differences, %†
Low (n=425 516) Medium (n=656 348) High (n=398 444) Medium vs Low High vs Low
Defect-free care‡ 86.4 87.3 87.4 2.9 3.0
Anticoagulation for AF patients 93.0 93.5 93.7 1.8 2.8
Antithrombotics at discharge 97.2 97.5 97.6 2.3 2.6
Dysphagia screening 77.5 78.7 77.5 2.9 0.0
VTE prophylaxis 96.6 97.2 97.1 3.4 2.5
Statins at discharge 89.9 90.4 90.8 1.9 3.1
Assessed for/received rehabilitation 92.0 92.5 92.4 1.8 1.3
Antithrombotics by day 2 96.1 96.4 96.3 2.0 1.1
Smoking cessation counseling 95.5 96.1 95.5 2.9 0.1
Stroke education 72.1 73.3 71.0 2.7 2.4
Timeliness metrics
tPA Rx (arrive ≤3.5 h, treat ≤4.5 h) 39.3 40.5 37.9 2.5 2.9
tPA Rx (arrive ≤2 h, treat ≤3 h) 74.1 75.2 74.9 2.5 1.9
Door-to-imaging ≤25 min 24.2 24.5 23.8 0.6 0.9
Door-to-needle ≤60 min (tPA only) 35.5 36.0 34.2 1.2 2.6
Cared for in stroke unit 64.5 66.9 65.7 5.1 2.5
AF indicates atrial ﬁbrillation; HRR, hospital referral region; Rx, prescription; tPA, tissue plasminogen activator; VTE, venous thromboembolism.
*Based on availability per 100 000 residents of neurologists, radiologists, emergency room physicians, physical medicine and rehabilitation specialists, hospital-based registered nurses,
and inpatient hospital beds.
†A standardized difference greater than 10% is typically considered meaningful.14
‡Receipt of all stroke performance metrics for which the patient was eligible. Eligibility was deﬁned separately for individual metrics.
Table 3. Multivariable Adjusted* Odds Ratios (95% CIs) Comparing Patient Outcomes by Healthcare Resource Availability
Outcome Low Medium P Value High P Value
In-hospital complications
Venous thromboembolism Ref 1.13 (0.78–1.62) 0.52 1.04 (0.74–1.45) 0.84
tPA-related complications† Ref 1.08 (0.83–1.42) 0.56 0.82 (0.58–1.15) 0.24
In-hospital mortality Ref 1.09 (1.02–1.16) 0.01 1.00 (0.92–1.09) 0.92
Discharged to home Ref 0.99 (0.95–1.03) 0.70 0.97 (0.92–1.02) 0.29
Ambulating independently at discharge Ref 1.01 (0.94–1.08) 0.79 0.96 (0.89–1.05) 0.38
Length of inpatient stay, d Ref 1.00 (0.98–1.02) 0.89 1.001 (0.99–1.03) 0.50
*Adjusted for patient and hospital characteristics.
†Tissue plasminogen activator (tPA) patients only.
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regardless of event severity or differences in comorbidity
burden. One likely mechanism for these patterns is improved
adherence to evidence-based metrics in centers with higher
resource availability. In one analysis of 4897 patients in the Paul
Coverdell National Acute Stroke Registry, Reeves and col-
leagues20 reported that involvement of a neurologist in stroke
care was associated with a 4.9% increase in the proportion of
ﬁlled care opportunities. Consistent with this prior work, we
found that increasing availability of neurologists was associated
with higher adjusted rates of defect-free care. In another
analysis of Medicare claims data, patients treated by neurol-
ogists had signiﬁcantly lower adjusted 90-day mortality rates
comparedwith thosewhowere not. These differencesmay have
been due to increased adherence to evidence-based guidelines,
such as prescription of warfarin, and a higher proportion of
patients who were discharged to inpatient rehabilitation
facilities.21
Despite the evidence supporting increased access to
specialists for delivery of high-quality stroke care, less is
known about the inﬂuence of healthcare resource regional
variation on quality and outcomes. In a landmark study
assessing quality and cost differences among Medicare
beneﬁciaries, Baicker and colleagues6 reported that areas
with a higher number of specialists per capita had higher
healthcare costs and were less likely to deliver high-quality
care; availability of nurses was not associated with variation in
quality or cost. Additionally, increasing the number of general
practitioners by 1 per 10 000 per state, while decreasing the
number of specialists, was associated with a reduction in
spending and a 10-place rise in the state’s quality rank.
However, the authors considered 24 quality measures for the
treatment of both chronic and acute conditions, and prior
work suggests the importance of specialist availability,
particularly for acute conditions.22
We extend this prior work by considering specialist
availability, as well as a broader set of healthcare resources
and additional relevant clinical outcomes, such as in-hospital
complications, in a large national database of acute stroke.
We did not ﬁnd signiﬁcant associations with quality or in-
hospital outcomes across regions categorized as having low-,
medium-, or high-resource availability. One possible explana-
tion for our ﬁndings is the nature of the analytic population.
GWTG-Stroke is a large national quality improvement initiative
that has been shown to be representative of the larger stroke
population in the United States.23 However, GWTG-Stroke is a
network of hospitals that facilitates sharing of best practices
and quality improvement strategies, and evidence suggests
that program participation is linked to sustained improve-
ments in delivery of evidence-based quality metrics indepen-
dent of hospital volume, bed size, or teaching status.11
Absolute adherence to quality metrics were high among most
participating hospitals. Therefore, it is possible that GWTG-
Stroke hospitals represent a select sample of centers that are
particularly focused on improving quality of care and
outcomes, which may minimize quality differences attributa-
ble to variation in resource availability. Another possible
explanation for these ﬁndings is the choice of resources for
assessment. We selected 6 resources relevant to the care of
acute stroke patients that were collected as part of the DAH
project. Nevertheless, there are likely other healthcare
resources relevant to acute stroke care, and it is possible
that differences in the number of clinicians and in-hospital
beds may be too small to fully reﬂect important differences in
resource availability.
Study Limitations
Several limitations to our analysis are worth noting. First, a
number of factors likely inﬂuence regional availability of
healthcare resources, including variation in stroke incidence,
complexity of patients, and event severity. While the detailed
clinical information captured in GWTG-Stroke supports adjust-
ment for differences in case mix, it is possible that there were
unmeasured characteristics of the patient population that
inﬂuenced our ﬁndings. Second, we did not have speciﬁc
information on regional availability of stroke unit stafﬁng and
resources. For example, we did not have information on the
use of a telemedicine program at each hospital, and access to
such programs may reduce the inﬂuence of geographic
variation in stroke resources on acute stroke outcomes. Third,
our clinical end point analysis focused on in-hospital
outcomes including mortality and complications, yet delivery
of high-quality care/evidence-based medications at dis-
charge, stroke education, and rehabilitation services may
result in longer-term beneﬁts that are not apparent for several
months after hospital discharge. Fourth, residual measured
and unmeasured confounding may have inﬂuenced these
ﬁndings. Additionally, we deﬁned HRRs as low, medium, and
high based on DAH data, which is only publicly available for
2006; therefore, we were unable to account for changing
resource availability over the study period (2006–2013). Fifth,
effect estimates for many analyses are small in magnitude
and, while statistically signiﬁcant, may not represent clinically
signiﬁcant differences. Finally, we focused on the availability
of hospital-based resources for acute stroke. Availability of
primary care and other providers in the outpatient setting may
inﬂuence prestroke and poststroke medication adherence and
access to secondary prevention strategies.
Conclusions
Signiﬁcant variation exists in regional availability of healthcare
resources for the treatment of acute ischemic stroke.
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However, among 1898 hospitals participating in GWTG-
Stroke, quality of care and in-hospital outcomes for acute
ischemic stroke did not differ signiﬁcantly by selected metrics
of regional resource availability. Further exploration of other
relevant markers of resource availability and outcomes is
warranted.
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SUPPLEMENTAL MATERIAL 
 
 Table S1. Distribution of 6 Healthcare Resources Per 100,000 population across 306 HRRs in the 
DAH. 
Variables N Mean STD Median Q1 Q3 Min Max 
Neurologists 306 3.313 1.151 3.154 2.524 3.880 0.875 9.782 
Radiologists 306 8.632 1.889 8.532 7.374 9.630 2.834 14.497 
ER physicians 306 9.009 2.919 8.862 6.888 10.623 1.529 20.238 
PM&R specialists 306 2.064 0.871 1.926 1.486 2.566 0.307 5.490 
Hospital-based RNs 306 3.730 0.665 3.725 3.288 4.215 2.112 5.732 
Inpatient hospital beds 306 2.515 0.618 2.407 2.055 2.909 1.445 4.707 
 
HRR indicates hospital referral region; DAH: Dartmouth Atlas of Health Care; ER: emergency 
room; PM&R: physical medicine and rehabilitation specialist; RN: registered nurse
Table S2. Clinical Outcomes in GWTG-Stroke
*
 
Length of stay Univariate RR p-value Adjusted RR p-value 
Neurologists 1.03 (1.03, 1.04) <0.0001 1.01 (1.00, 1.02) 0.0068 
Radiologists 1.01 (1.01, 1.02) <0.0001 1.00 (1.00, 1.00) 0.9539 
ER physicians 0.98 (0.98, 0.99) <0.0001 0.99 (0.99, 0.99) <0.0001 
PM&R specialists 1.05 (1.04, 1.06) <0.0001 1.04 (1.03, 1.05) <0.0001 
Hospital-based RNs 1.04 (1.03, 1.06) <0.0001 1.01 (1.00, 1.02) 0.1505 
Inpatient hospital beds 1.11 (1.09, 1.13) <0.0001 1.06 (1.05, 1.08) <0.0001 
Defect-free care Univariate OR p-value Adjusted OR p-value 
Neurologists 1.09 (1.06, 1.12) <0.0001 1.04 (1.01, 1.06) 0.0065 
Radiologists 1.04 (1.03, 1.06) <0.0001 1.02 (1.00, 1.03) 0.0561 
ER physicians 1.03 (1.01, 1.05) 0.0003 1.01 (1.00, 1.03) 0.0778 
PM&R specialists 1.11 (1.07, 1.15) <0.0001 1.05 (1.02, 1.09) 0.0047 
Hospital-based RNs 0.91 (0.86, 0.96) 0.0012 1.02 (0.96, 1.08) 0.5401 
Inpatient hospital beds 0.77 (0.72, 0.83) <0.0001 0.91 (0.85, 0.97) 0.0052 
In-hospital mortality Univariate OR p-value Adjusted OR p-value 
Neurologists 1.02 (1.00, 1.04) 0.0116 1.01 (0.99, 1.04) 0.2581 
Radiologists 1.02 (1.01, 1.03) 0.0031 1.00 (0.99, 1.02) 0.7609 
ER physicians 1.00 (0.99, 1.01) 0.7689 0.99 (0.98, 1.01) 0.2850 
PM&R specialists 1.06 (1.03, 1.08) <0.0001 1.01 (0.98, 1.05) 0.4469 
Hospital-based RNs 0.96 (0.93, 1.00) 0.0470 1.03 (0.97, 1.08) 0.3059 
Inpatient hospital beds 0.98 (0.94, 1.03) 0.4287 1.06 (1.00, 1.13) 0.0538 
Discharged to home Univariate OR p-value Adjusted OR p-value 
Neurologists 0.96 (0.95, 0.97) <0.0001 1.00 (0.99, 1.01) 0.889 
Radiologists 0.97 (0.96, 0.98) <0.0001 1.00 (0.99, 1.01) 0.910 
ER physicians 0.99 (0.99, 1.00) 0.043 1.00 (1.00, 1.01) 0.416 
PM&R specialists 0.94 (0.93, 0.96) <0.0001 0.99 (0.97, 1.01) 0.366 
Hospital-based RNs 0.97 (0.95, 1.00) 0.040 0.97 (0.94, 1.00) 0.041 
Inpatient hospital beds 0.98 (0.95, 1.01) 0.203 0.91 (0.87, 0.94) <0.0001 
Ambulating independently at Univariate OR p-value Adjusted OR p-value 
discharge     
Neurologists 0.98 (0.96, 1.00) 0.016 0.99 (0.97, 1.01) 0.306 
Radiologists 0.98 (0.97, 0.99) 0.001 0.99 (0.98, 1.01) 0.245 
ER physicians 1.00 (0.99, 1.01) 0.609 1.00 (0.98, 1.01) 0.563 
PM&R specialists 0.99 (0.97, 1.02) 0.687 1.01 (0.97, 1.04) 0.669 
Hospital-based RNs 0.97 (0.93, 1.02) 0.200 0.95 (0.90, 1.01) 0.124 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*
ORs are for every 1 unit increase per 1,000 residents for inpatient hospital beds and hospital-based RNs, 
and for every 1 unit increase per 100,000 residents for neurologists, ER physicians, PM&R specialists, 
and radiologists 
ER indicates emergency room; GWTG-Stroke, Get With The Guidelines-Stroke; OR, odds ratio; PM&R, 
physical medicine and rehabilitation specialist; RN, registered nurse; RR, risk ratio; t-PA, tissue 
plasminogen activator 
 
Inpatient hospital beds 0.97 (0.92, 1.03) 0.352 0.95 (0.88, 1.03) 0.199 
t-PA-related complications Univariate OR p-value Adjusted OR p-value 
Neurologists 0.95 (0.90, 1.00) 0.061 0.98 (0.90, 1.05) 0.520 
Radiologists 0.96 (0.92, 1.00) 0.043 0.96 (0.92, 1.00) 0.054 
ER physicians 0.95 (0.92, 0.99) 0.017 0.97 (0.93, 1.00) 0.067 
PM&R specialists 0.83 (0.71, 0.96) 0.014 0.84 (0.71, 1.00) 0.052 
Hospital-based RNs 0.96 (0.85, 1.08) 0.472 0.90 (0.76, 1.07) 0.223 
Inpatient hospital beds 1.09 (0.83, 1.43) 0.523 0.99 (0.74, 1.32) 0.944 
Venous thromboembolism Univariate OR p-value Adjusted OR p-value 
Neurologists 1.07 (0.95, 1.21) 0.289 1.08 (0.96, 1.20) 0.197 
Radiologists 1.06 (1.00, 1.12) 0.063 1.03 (0.98, 1.09) 0.260 
ER physicians 1.00 (0.96, 1.04) 0.958 1.01 (0.95, 1.07) 0.754 
PM&R specialists 0.98 (0.74, 1.30) 0.896 0.91 (0.69, 1.19) 0.476 
Hospital-based RNs 0.97 (0.82, 1.15) 0.754 1.00 (0.76, 1.32) 0.990 
Inpatient hospital beds 0.73 (0.42, 1.29) 0.282 0.77 (0.44, 1.35) 0.362 
 
 Table S3. Hospital-level Outcomes in GWTG-Stroke. 
Outcomes Mean STD Median Q1 Q3 
In-Hospital Complications: Venous 1.90 3.06 1.42 0.97 2.08  
thromboembolism       
In-Hospital Complications: t-PA related 15.48 11.47 12.84 9.71 17.45  
complications       
In-hospital mortality 5.00 1.78 4.92 3.92 6.12  
Discharged to home 47.52 5.87 47.21 43.82 50.65  
Ambulatory independently at discharge 51.08 8.05 50.85 46.18 55.41  
Length of Hospital stay in days >=4 53.62 9.55 54.63 48.17 59.38  
 
Table S4. Multivariable Adjusted* Odds Ratios (95% CI) Comparing Patient Outcomes by 
Healthcare Resource Availability (reclassified). 
Outcome Low Medium p-value High p-value 
 (N=46) (N=150)  (N=110)  
In-hospital complications      
Venous thromboembolism ref 0.96 (0.66 , 1.40) 0.831 0.87 (0.56 , 1.35) 0.540 
t-PA related complications
†
 ref 1.09 (0.79 , 1.51) 0.587 0.91 (0.58 , 1.42) 0.669 
In-hospital mortality ref 1.18 (1.08 , 1.29) <0.001 1.16 (1.05 , 1.27) 0.002 
Discharged to home ref 1.00 (0.95 , 1.06) 0.943 0.99 (0.93 , 1.04) 0.649 
Ambulating independently at discharge ref 0.99 (0.90 , 1.08) 0.805 0.96 (0.87 , 1.05) 0.357 
Length of inpatient stay (days) ref 1.00 (0.98 , 1.02) 0.949 1.01 (0.98 , 1.04) 0.480 
*
Adjusted for patient and hospital characteristics 
†
t-PA patients only 
t-PA indicates tissue plasminogen activator.  
